γ-Glutamyl carboxylase activity in experimental tumor tissues: A biochemical basis for vitamin K dependence of cancer procoagulant

Maria Carla Roncaglioni, Anna Paola Bolognese Dalessandro, Bruno Casali, Cees Vermeer, Maria Benedetta Donati

Research output: Contribution to journalArticle

Abstract

Rabbit V2 carcinoma tissues have been described to possess a procoagulant activity with specific characteristics; this material has been purified and identified as a cysteine proteinase able to directly activate coagulation factor X. We have shown here that the procoagulant activity of V2 carcinoma extracts is depressed in warfarin-treated animals, thus suggesting that cancer procoagulant could represent a new vitamin K-dcpendent protein. The biochemical basis for this effect is offered by the identification of γ-glutamyl carboxylase in the microsomal fraction of tumor tissues. The V2 carcinoma has a carboxylase activity which is increased in warfarin-treated animals. An endogenous substrate of tumor carboxylase, the nature of which has not been identified, has been found 5-fold increased in warfarin-treated animals. The presence of γ-glutamyl carboxylase was also described in several murine tumors including both carcinomas and fibrosarcomas. It is worth mentioning that all the tumors tested produce a procoagulant with the peculiar characteristics of that described in V2 carcinoma. It is conceivable that cancer procoagulant could represent at least one of the substrates for γ-glutamyl carboxylase in these experimental tumor tissues.

Original languageEnglish
Pages (from-to)295-299
Number of pages5
JournalPathophysiology of Haemostasis and Thrombosis
Volume16
Issue number3-4
DOIs
Publication statusPublished - 1986

    Fingerprint

Keywords

  • Cancer procoagulant
  • Tumors, experimental
  • Warfarin
  • γ-Glutamyl carboxylase

ASJC Scopus subject areas

  • Hematology
  • Physiology (medical)

Cite this